Tech Center 1600 • Art Units: 1615 1617 1621 1627 1628 1629
This examiner grants 59% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18739657 | COMBINATION | Non-Final OA | Novartis AG |
| 17086409 | PRODRUG COMPOSITIONS AND METHODS OF TREATMENT | Final Rejection | AQUESTIVE THERAPEUTICS, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy